Sumitomo Chemical India Limited - agriculture in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24110MH2000PLC124224 Incorporated 15 February 2000 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: SUMICHEM · BSE: 542920 Public Limited Company agriculture Nifty 500
Data last updated
Market Cap
₹16,377 Cr
SUMICHEM · NSE
Share Price
₹327.85
-0.08% today
Revenue
₹3,238 Cr
FY 2025-26 · +2.9% YoY
EBITDA
₹655 Cr
Margin 20.2%
Net Profit
₹510 Cr
FY 2025-26 · +5.2% YoY
P/E (TTM)
28.4x
P/B 4.2x
ROE
17.3%
ROCE 22.7%
Debt / Equity
0.02
Interest cover 1.4x

About Sumitomo Chemical India Limited

Data last updated:

Sumitomo Chemical India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Sumitomo Chemical Company Limited. It operates in the crop protection segment of the agriculture sector. It was incorporated on 15 February 2000 and has been in existence for over 26 years.

Sumitomo Chemical India is part of the Nifty 500 and BSE 500 indices.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24110MH2000PLC124224. Its GSTIN is 27AAECS3750L1Z2 (Maharashtra). The company holds 36 GST registrations, of which 25 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 542920 and NSE: SUMICHEM.

The company has an authorised share capital of ₹500 Cr and a paid-up capital of ₹499.15 Cr. It was formerly known as Sumitomo Chemical India Private Limited. It is led by directors including Chetan Shantilal Shah (Managing Director) and Suresh Ramachandran (Managing Director).

Its last annual general meeting (AGM) was held on 27 July 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Bldg No.1 GF Shant Manor Co – Op Housing Society Ltd Chakravarti Ashok ‘X’ Road Kandivli (E), Mumbai, Maharashtra, India – 400101.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹3,238.32 Cr, a growth of 2.9% compared to the previous year. For the same year it recorded a net profit of ₹510.41 Cr (net margin 15.8%) and EBITDA of ₹655.4 Cr (EBITDA margin 20.2%). The net worth stands at ₹3,389.67 Cr (up 16.8% YoY). Total assets are valued at ₹3,498 Cr (up 16.9% YoY).

The company has about 2,414 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Sumitomo Chemical India. As per MCA filings, the company has open charges of ₹85 Lakh and satisfied charges of ₹12.05 Cr on record. Court records list 1,121 cases involving the company, including 1,002 filed by the company and 119 filed against it; 281 cases are pending. The company has 3 deals on record (3 market trades); the latest was in October 2022. Its 7 peer companies in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Bayer Cropscience Limited with revenue of ₹5,593.1 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 335 overdue payments to 158 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sumichem.co.in.

Company details

CIN L24110MH2000PLC124224
Registration Number 124224
Incorporation Date 15 February 2000
ROC Mumbai
Listing Status Listed - Listed on NSE (SUMICHEM); Listed on BSE (542920)
Company Status Active
Date of Last AGM 27 July 2026
Date of Balance Sheet 31 March 2026
Parent Company Sumitomo Chemical Company Limited
Compliance Status Active Compliant

CIN history

Sumitomo Chemical India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24110MH2000PLC124224, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24110MH2000PLC124224Current
U24110MH2000PTC124224Previous
U24110MH2000PLC124224Previous

Recognitions & Rankings of Sumitomo Chemical India

Stock market indices
Nifty 500 BSE 500

Contact details

Sumitomo Chemical India Limited's registered office is in Mumbai, Maharashtra. Its website is sumichem.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Bldg No.1 GF Shant Manor Co – Op Housing Society Ltd Chakravarti Ashok ‘X’ Road Kandivli (E), Mumbai, Maharashtra, India – 400101
  • Industry
    Agriculture, Crop Protection

To see the full contact details of Sumitomo Chemical India Limited, buy the company report.

Comprehensive company report
Sumitomo Chemical India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sumitomo Chemical India operates one associated brand: Sumitomo Chemical India. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and markets crop protection products, bio-pesticides and animal feed additivessumichem.co.in

Business activity

The main business activity of Sumitomo Chemical India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sumitomo Chemical India Limited, buy the company report.

Financials of Sumitomo Chemical India Limited

FY 2025-26 filings available

Sumitomo Chemical India Limited reported revenue of ₹3,238.32 Cr (up 2.9% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹3,238 Cr
+2.9% YoY
EBITDA
₹655 Cr
+3.6% YoY
Profit After Tax
₹510 Cr
+5.2% YoY
Net Worth
₹3,390 Cr
+16.8% YoY
Total Assets
₹3,498 Cr
+16.9% YoY
Total Debt
₹63.30 Cr
+22.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,2383,1492,8443,5113,0612,6452,425
Revenue growth+2.9%+10.7%-19.0%+14.7%+15.7%+9.1%-
EBITDA655633475667602488304
EBITDA margin+20.2%+20.1%+16.7%+19.0%+19.7%+18.5%+12.5%
Profit before tax728680503654576453267
Net profit510485352485418340225
Net profit margin+15.8%+15.4%+12.4%+13.8%+13.7%+12.9%+9.3%
EPS (₹)10.8810.137.4010.068.496.924.10
Balance sheet
Total assets3,4982,9922,5012,4381,9871,6031,282
Net worth3,3902,9012,4422,3821,9271,5411,222
Total debt63.3051.8930.2533.9737.5832.6435.58
Cash & bank12142.7918330379.1224293.51
Net working capital1,5051,6171,5381,6321,157950836
Cash flow
Cash from operations446452757389222425221
Cash from investing(332)(392)(420)(327)(290)(283)(118)
Cash from financing(82.88)(67.92)(337)(72.55)(62.64)(47.06)(61.39)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue9071,0636845689301,057679642
Revenue growth (YoY)-2.4%+0.6%+0.6%-11.5%-5.9%+26.0%--
Other income43.5974.1832.2136.9638.8038.7931.6231.23
EBITDA18623313483.38218219120106
EBITDA margin+20.5%+21.9%+19.6%+14.7%+23.4%+20.7%+17.6%+16.5%
Depreciation17.2717.2316.9116.7416.7515.7216.4219.06
Interest1.922.001.912.022.241.661.661.79
Profit before tax210288148102238241133116
Tax52.7673.7236.2425.7760.0962.5033.3229.07
Net profit15721511175.8117817899.7887.43
EPS (₹)3.144.302.231.523.563.572.001.74
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,1863,0902,8333,5113,0602,6432,423
Revenue growth+3.1%+9.1%-19.3%+14.7%+15.8%+9.1%-
EBITDA650623474668603488304
EBITDA margin+20.4%+20.2%+16.7%+19.0%+19.7%+18.5%+12.6%
Profit before tax727674503655586453267
Net profit554502369503433345226
Net profit margin+17.4%+16.2%+13.0%+14.3%+14.2%+13.1%+9.3%
EPS (₹)10.8810.067.4110.098.696.924.12
Balance sheet
Total assets3,4772,9742,4902,4361,9841,5901,269
Net worth3,3842,8972,4402,3801,9241,5281,209
Total debt53.0144.9925.2533.9737.5832.6435.58
Cash & bank11935.8516930378.6523182.72
Net working capital1,4911,6011,5241,6301,154937823
Cash flow
Cash from operations443458756389223424222
Cash from investing(329)(405)(426)(327)(281)(282)(118)
Cash from financing(81.17)(65.11)(331)(72.55)(62.55)(47.06)(61.38)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue8911,0546715529141,048665622
Revenue growth (YoY)-2.6%+0.6%+1.0%-11.4%-5.9%+26.0%--
Other income43.3673.9631.9436.8238.7038.6231.3631.27
Total expenses708819539471697828547521
EBITDA18323513380.40217220117101
EBITDA margin+20.6%+22.3%+19.8%+14.6%+23.7%+21.0%+17.6%+16.2%
Depreciation16.2416.2315.9515.7915.8714.9815.6118.28
Interest1.581.641.561.661.901.401.381.49
Profit before tax20929114799.77238242132113
Tax52.7874.7336.5224.9359.9862.0833.2728.29

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 05 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue9071,0636845689301,057679642
Revenue growth (YoY)-2.4%+0.6%+0.6%-11.5%-5.9%+26.0%--
Other income43.5974.1832.2136.9638.8038.7931.6231.23
EBITDA18623313483.38218219120106
EBITDA margin+20.5%+21.9%+19.6%+14.7%+23.4%+20.7%+17.6%+16.5%
Depreciation17.2717.2316.9116.7416.7515.7216.4219.06
Interest1.922.001.912.022.241.661.661.79
Profit before tax210288148102238241133116
Tax52.7673.7236.2425.7760.0962.5033.3229.07
Net profit15721511175.8117817899.7887.43
EPS (₹)3.144.302.231.523.563.572.001.74
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,2383,1492,8443,5113,0612,6452,425
Revenue growth+2.9%+10.7%-19.0%+14.7%+15.7%+9.1%-
Other income14712095.6744.8526.7918.5710.71
Total expenses2,5832,5162,3692,8442,4592,1572,121
Employee cost274265232218202194179
EBITDA655633475667602488304
EBITDA margin+20.2%+20.1%+16.7%+19.0%+19.7%+18.5%+12.5%
Depreciation66.1266.0662.1951.8844.8146.5840.97
Interest8.446.595.696.217.986.937.09
Profit before tax728680503654576453267
Tax18517413315215210861.83
Net profit510485352485418340225
Net profit margin+15.8%+15.4%+12.4%+13.8%+13.7%+12.9%+9.3%
EPS (₹)10.8810.137.4010.068.496.924.10
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital499499499499499499499
Reserves & surplus2,8912,4021,9421,8831,4281,042723
Shareholders' funds (net worth)3,3902,9012,4422,3821,9271,5411,222
Minority interest4.113.942.980.000.000.100.00
Secured loans1.500.000.000.000.000.000.00
Unsecured loans61.8051.8930.2533.9737.5832.6435.58
Total debt63.3051.8930.2533.9737.5832.6435.58
Total liabilities3,4982,9922,5012,4381,9871,6031,282
Assets
Gross block928858815671583461426
Net block577556563430390309319
Capital work in progress19.7628.4922.6971.2035.2214.2110.27
Investments1,15352434623935629086.11
Inventories766704610889938754588
Sundry debtors736783716946843848850
Cash & bank balances12142.7918330379.1224293.51
Loans & advances8311,033817411306169128
Total current assets2,4532,5632,3272,5492,1662,0141,660
Total current liabilities9489467899171,0091,064824
Net working capital1,5051,6171,5381,6321,157950836
Total assets3,4982,9922,5012,4381,9871,6031,282
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash38.2346.6446.8957.2518892.6150.46
Net cash from operating activities446452757389222425221
Net cash from investing activities(332)(392)(420)(327)(290)(283)(118)
Net cash from financing activities(82.88)(67.92)(337)(72.55)(62.64)(47.06)(61.39)
Net change in cash30.68(8.40)(0.26)(10.36)(131)95.6942.15
Closing cash12142.7918330379.1224293.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.9%+10.7%-19.0%+14.7%+15.7%+9.1%-
EBITDA growth+3.6%+33.2%-28.8%+10.9%+23.2%+60.7%-
PBT growth+7.0%+35.3%-23.1%+13.6%+27.0%+70.1%+2.6%
Net income growth+5.2%+37.8%-27.4%+16.0%+23.1%+50.8%-
Revenue CAGR (3Y)-2.7%+0.9%+2.5%+13.1%+11.2%+11.4%-
EBITDA CAGR (3Y)-0.6%+1.7%-0.9%+30.0%+28.5%+30.5%-
Profitability & leverage
Net income margin+16.8%+16.1%+13.0%+14.3%+13.8%+13.1%+8.4%
Return on capital employed+22.7%+25.0%+20.6%+29.9%+32.5%+31.9%+25.6%
Return on net worth+17.3%+19.0%+15.3%+23.3%+24.4%+25.0%+19.9%
Debt / equity0.020.020.010.020.020.020.02
Long-term debt / equity0.010.010.010.010.010.010.01
Interest cover1.431.161.381.011.431.572.70
Efficiency & per share
Fixed asset turnover3.633.763.835.605.865.976.29
Inventory turnover4.414.793.793.843.623.943.82
Debtors turnover4.264.203.423.923.623.123.19
EPS (₹)10.8810.137.4010.068.496.924.10
Dividend per share (₹)1.301.205.901.201.000.800.75
Book value per share (₹)67.9158.1248.9147.7238.6130.8824.48
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue8911,0546715529141,048665622
Revenue growth (YoY)-2.6%+0.6%+1.0%-11.4%-5.9%+26.0%--
Other income43.3673.9631.9436.8238.7038.6231.3631.27
Total expenses708819539471697828547521
EBITDA18323513380.40217220117101
EBITDA margin+20.6%+22.3%+19.8%+14.6%+23.7%+21.0%+17.6%+16.2%
Depreciation16.2416.2315.9515.7915.8714.9815.6118.28
Interest1.581.641.561.661.901.401.381.49
Profit before tax20929114799.77238242132113
Tax52.7874.7336.5224.9359.9862.0833.2728.29
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,1863,0902,8333,5113,0602,6432,423
Revenue growth+3.1%+9.1%-19.3%+14.7%+15.8%+9.1%-
Other income14611996.1245.0635.9418.9710.84
Total expenses2,5352,4672,3582,8432,4582,1552,119
Employee cost257246226217201193178
EBITDA650623474668603488304
EBITDA margin+20.4%+20.2%+16.7%+19.0%+19.7%+18.5%+12.6%
Depreciation62.6063.2661.4951.8644.7946.5640.92
Interest7.145.565.356.207.896.837.05
Profit before tax727674503655586453267
Tax18417213415215210861.66
Net profit554502369503433345226
Net profit margin+17.4%+16.2%+13.0%+14.3%+14.2%+13.1%+9.3%
EPS (₹)10.8810.067.4110.098.696.924.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital499499499499499499499
Reserves & surplus2,8852,3971,9411,8811,4251,029710
Shareholders' funds (net worth)3,3842,8972,4402,3801,9241,5281,209
Secured loans0.000.000.000.000.000.000.00
Unsecured loans53.0144.9925.2533.9737.5832.6435.58
Total debt53.0144.9925.2533.9737.5832.6435.58
Total liabilities3,4772,9742,4902,4361,9841,5901,269
Assets
Gross block841777738671582461425
Net block499482489430390309319
Capital work in progress19.7628.4922.6971.2035.2214.2110.27
Investments1,22660142523935729186.87
Inventories761698605889938754587
Sundry debtors711763707946843846848
Cash & bank balances11935.8516930378.6523182.72
Loans & advances8301,033816411306169128
Total current assets2,4212,5302,2982,5482,1651,9991,646
Total current liabilities9309297739181,0111,063823
Net working capital1,4911,6011,5241,6301,154937823
Total assets3,4772,9742,4902,4361,9841,5901,269
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash34.3445.5846.5656.7717781.8239.29
Net cash from operating activities443458756389223424222
Net cash from investing activities(329)(405)(426)(327)(281)(282)(118)
Net cash from financing activities(81.17)(65.11)(331)(72.55)(62.55)(47.06)(61.38)
Net change in cash33.19(11.23)(0.99)(10.21)(120)95.1342.53
Closing cash11935.8516930378.6523182.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.1%+9.1%-19.3%+14.7%+15.8%+9.1%-
EBITDA growth+4.3%+31.5%-29.1%+10.9%+23.6%+60.2%-
PBT growth+7.8%+33.9%-23.2%+11.9%+29.3%+69.5%+3.6%
Net income growth+10.4%+35.9%-26.6%+16.2%+25.5%+52.6%-
Revenue CAGR (3Y)-3.2%+0.3%+2.3%+13.2%+11.2%+11.4%+42.6%
EBITDA CAGR (3Y)-0.9%+1.1%-0.9%+30.0%+28.7%+30.5%+44.6%
Profitability & leverage
Net income margin+17.1%+16.2%+13.1%+14.3%+14.2%+13.1%+8.5%
Return on capital employed+22.8%+24.9%+20.7%+29.9%+33.2%+32.2%+25.9%
Return on net worth+17.3%+18.8%+15.3%+23.4%+25.1%+25.2%+20.2%
Debt / equity0.020.010.010.020.020.020.03
Long-term debt / equity0.010.010.010.010.010.010.01
Interest cover1.210.991.301.011.411.552.68
Efficiency & per share
Fixed asset turnover3.944.084.025.615.875.966.29
Inventory turnover4.374.743.793.843.623.943.83
Debtors turnover4.324.203.433.923.623.123.20
EPS (₹)10.8810.067.4110.098.696.924.12
Dividend per share (₹)1.301.205.901.201.000.800.75
Book value per share (₹)67.8058.0348.8947.6838.5530.6124.22

To see the full year-wise statements and ratios of Sumitomo Chemical India Limited, buy the company report.

Board of directors and KMP of Sumitomo Chemical India Limited

Sumitomo Chemical India Limited currently reports 10 directors and 1 key managerial person. 23 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Sushil Champaklal MarfatiaWhole-Time Director10 May 20197 Years 5 MonthsCurrent
Tadashi KatayamaDirector31 Aug 20197 Years 2 MonthsCurrent
Anandmohan TiwariDirector31 Aug 20260 Years 2 MonthsCurrent
Masanori UzawaDirector10 Jul 20206 Years 3 MonthsCurrent
Preeti Gautam MehtaDirector31 Aug 20197 Years 2 MonthsCurrent
Chetan Shantilal ShahManaging Director01 Sep 20197 Years 2 MonthsCurrent
Showing 6 of 11 current directors and KMP. View all directors and KMP

Peer comparison

Sumitomo Chemical India Limited is compared with the 7 companies closest to it by revenue in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Bayer Cropscience Limited₹5,593.1 Cr (FY 2025)8.0%Thane, Maharashtra, India
Gharda Chemicals Limited₹3,649.01 Cr (FY 2025)20.0%Mumbai, Maharashtra, India
Sumitomo Chemical India Limitedthis company₹3,238.32 Cr (FY 2026)₹510.41 Cr15.8%2.9%2,414Mumbai, Maharashtra, India
Southern Petrochemical Industries Corporation Limited₹3,100.25 Cr (FY 2025)58.0%Chennai, Tamil Nadu, India
Adama India Private Limited₹2,509.85 Cr (FY 2025)-4.0%Medchal Malkajgiri, Telangana, India
Bayer Vapi Private Limited₹2,200.3 Cr (FY 2025)-10.0%Vapi, Gujarat, India
Meghmani Organics Limited₹2,123.62 Cr (FY 2025)32.0%Ahmedabad, Gujarat, India
Willowood Chemicals Limited₹2,111.28 Cr (FY 2025)16.0%Kolkata, West Bengal, India

To see the full peer comparison of Sumitomo Chemical India Limited, buy the company report.

Auditor

Sumitomo Chemical India Limited is audited by S R B C & CO LLP for the financial year 2024.

Auditor firmFinancial yearFirm registration number
S R B C & CO LLPFY 2024324982E/E300003

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 75.00%, foreign institutional investors hold 3.00%, domestic institutional investors hold 9.40% and retail and other public shareholders hold 12.60%.

Promoters: 75.00%DII (Domestic Institutional): 9.40%FII (Foreign Institutional): 3.00%Retail & Others: 12.60%
Sep 2026
QUARTER
75.00% Promoters
9.40% DII (Domestic Institutional)
3.00% FII (Foreign Institutional)
12.60% Retail & Others
Promoter holding - history
Now 75.00% · Sep 2026High 75.00% · Dec 2025Low 75.00% · Dec 2025
74%74.5%75%75.5%76%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 75.00%Mar 2026: 75.00%Jun 2026: 75.00%Sep 2026: 75.00%75.00%75.00%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters75.00%75.00%75.00%75.00%
Public25.00%25.00%25.00%25.00%

Charges & borrowings

Open charges
₹85 Lakh
Satisfied charges
₹12.05 Cr
Breakdown by lending institutions
The Maharashtra State Financial Corporation₹0.65 Cr
Union Bank of India₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Feb 199290141728Union Bank of India₹20 LakhOpen
19 Feb 199290141726The Maharashtra State Financial Corporation₹12.75 LakhOpen
16 Oct 199190149194The Maharashtra State Financial Corporation₹52.25 LakhOpen
13 May 200910165536Bank of Baroda₹4.85 CrSatisfied
24 Oct 199480061074Bank of Baroda₹7.2 CrSatisfied

To see the full charge records of Sumitomo Chemical India Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Sumitomo Chemical India Limited has 3 deals on record (3 market trades); the latest was in October 2022.

Total deals
3
Market trades
3

Deals on record (3 of 3)

WhenDealAmountParties
Oct 2022Market trade₹13.69 CrBuyer: Ishares Msci India Small-Cap Etf, an individual
Seller: Ishares Core Emerging Markets Mauritius Co, Ishares India Sc Mauritius Company
Oct 2022Market trade₹13.24 CrBuyer: Ishares Msci India Small-Cap Etf, an individual
Seller: Ishares Core Emerging Markets Mauritius Co, Ishares India Sc Mauritius Company
Sep 2022Market trade₹15.15 CrBuyer: Ishares Msci India Small-Cap Etf, an individual
Seller: Ishares Core Emerging Markets Mauritius Co, Ishares India Sc Mauritius Company

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Sumitomo Chemical India Limited was last rated by Crisil on 31 Jan 2020.

Rating agencyRated onRating
Crisil31 Jan 2020

To see the full credit ratings and regulatory alerts of Sumitomo Chemical India Limited, buy the company report.

MSME payment delays

Sumitomo Chemical India Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 335 overdue payments to 158 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 158)

SupplierAmount dueDue sinceReported on
Bsa Polycontainer Private Limited
Prarthana Packaging Industries
an individual supplier
an individual supplier
Dwij Polymers

To see the full MSME payment records of Sumitomo Chemical India Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Sumitomo Chemical India has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Barrix Agro Sciences Private LimitedU01122KA2011PTC056966

To see the full group structure of Sumitomo Chemical India Limited, buy the company report.

Employees & EPFO

Sumitomo Chemical India Limited has a workforce of 2,414 employees on its EPFO records as of Nov 29, 2024, across 11 active EPFO establishments.

Employee count
2,414
Active EPFO establishments
11
Employee growth
-0.94%

GST

Sumitomo Chemical India has 36 GST registrations: 25 active and 11 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
36
Active
25
Cancelled / inactive
11
GSTINStateStatusRegistered on
27AAECS3750L1Z2MaharashtraActive01 Jul 2017
27AAECS3750L2Z1MaharashtraActive26 Jul 2017
03AAECS3750L1ZCPunjabActive01 Jul 2017
05AAECS3750L1Z8UttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Sumitomo Chemical India Limited, buy the company report.

Recent activity

Sumitomo Chemical India Limited has 33 board changes on record since 2009: 11 appointments and 22 cessations. The latest: Anandmohan Tiwari was appointed as Director on 31 Aug 2026.

Appointed
Anandmohan Tiwari was appointed as Director.
AGM
Sumitomo Chemical India Limited last Annual general meeting of members was held on 27 Jul 2026 as per latest MCA records.
Filing
Sumitomo Chemical India Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Appointed
Sivaraman Narayanaswami was appointed as Director.
Ceased
Bhupendranath Bhargava ceased to be Director.
Appointed
Suresh Ramachandran was appointed as Managing Director.
Ceased
Pravinkumar Durlabhdas Desai ceased to be Company Secretary.
Appointed
Masanori Uzawa was appointed as Director.
Ceased
Kiyoshi Takayama ceased to be Whole-Time Director.
Appointed
Anil Kumar Shantilal Nawal was appointed as CFO.
Appointed
Chetan Shantilal Shah was appointed as Managing Director.
Ceased
Keiichi Sakata ceased to be Director.

33 earlier events are in the company report.

News

SUMICHEM: Q2 REVENUE 9.07B RUPEES VS 9.3B (YOY)
26 Oct 2026 · Exchange Update
SUMICHEM: Q2 CONS NET PROFIT 1.57B RUPEES VS 1.78B (YOY); EST 1.62B
26 Oct 2026 · Exchange Update
SUMICHEM: Q2 EBITDA 1.86B RUPEES VS 2.18B (YOY); Q2 EBITDA MARGIN 20.47% VS 23.45% (YOY)
26 Oct 2026 · Exchange Update

Frequently asked questions

Sumitomo Chemical India is an active public limited company based in Mumbai, Maharashtra, India. The company works in crop protection, within the agriculture industry. It was incorporated on 15 February 2000 (26+ years old) and is registered under CIN L24110MH2000PLC124224. Listed on BSE: 542920 and NSE: SUMICHEM.

Sumitomo Chemical India reported revenue of ₹3,238.32 Cr for FY 2025-26 (up 2.9% YoY) based on consolidated financials.

Sumitomo Chemical India has 11 current directors and KMP:

The latest financial statements of Sumitomo Chemical India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 July 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Sumitomo Chemical India is 27AAECS3750L1Z2, registered in Maharashtra. The company has 36 GST registrations in all, of which 25 are active and 11 are cancelled or inactive. Other active GSTINs include 27AAECS3750L2Z1 (Maharashtra), 03AAECS3750L1ZC (Punjab), 05AAECS3750L1Z8 (Uttarakhand).

The CIN (Corporate Identification Number) of Sumitomo Chemical India is L24110MH2000PLC124224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Sumitomo Chemical India is a listed company as per MCA records. Its shares are listed on both BSE (code: 542920) and NSE (symbol: SUMICHEM).

Sumitomo Chemical India has 1,121 court cases on record: 1,002 filed by the company and 119 filed against it. 281 are pending. Most are in the district courts.

Sumitomo Chemical India was incorporated on 15 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.

Sumitomo Chemical India has 3 deals on record (3 market trades); the latest was in October 2022.

The peers of Sumitomo Chemical India by revenue are Bayer Cropscience Limited, Gharda Chemicals Limited, Southern Petrochemical Industries Corporation Limited, Adama India Private Limited, Bayer Vapi Private Limited and 2 more, all in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anandmohan Tiwari was appointed as Director on 31 Aug 2026. Sivaraman Narayanaswami was appointed as Director on 01 Sep 2024. Bhupendranath Bhargava ceased to be Director on 26 Aug 2024. Sumitomo Chemical India has 33 board changes on record in total.